Evidence map›Paper›PMID 36499321›Full record

ReviewInternational journal of molecular sciences2022

Xylanase Inhibitors: Defense Players in Plant Immunity with Implications in Agro-Industrial Processing.

Silvio Tundo, Giulia Mandalà, Luca Sella, Francesco Favaron, Renesh Bedre, Raviraj M Kalunke

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Enzymatic Inhibitors of Aspartyl Protease EAP1 and Xylanase SRXL1 fromInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. The Overexpression ofPlants (Basel, Switzerland) · 2025
    Article
  8. Expression inInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Silvio TundoDepartment of Land, Environment, Agriculture, and Forestry (TESAF), University of Padova, 35020 Legnaro, Italy.ORCID 0000-0002-3638-7345
Giulia MandalàDepartment of Biotechnology, University of Verona, Strada Le Grazie 15, 37134 Verona, Italy.ORCID 0000-0001-7697-8310
Luca SellaDepartment of Land, Environment, Agriculture, and Forestry (TESAF), University of Padova, 35020 Legnaro, Italy.ORCID 0000-0003-4798-5874
Francesco FavaronDepartment of Land, Environment, Agriculture, and Forestry (TESAF), University of Padova, 35020 Legnaro, Italy.ORCID 0000-0002-9167-8823
Renesh BedreTexas A&M AgriLife Research and Extension Center, Texas A&M University System, Weslaco, TX 78596, USA.ORCID 0000-0001-8874-5100
Raviraj M KalunkeDonald Danforth Plant Science Center, 975 N Warson Rd, 7 Olivette, St. Louis, MO 63132, USA.ORCID 0000-0003-0110-2888
University of Padua · ITDonald Danforth Plant Science Center · USTexas A&M University System · USUniversity of Verona · IT

Funding

MUR-PON "Ricerca e innovazione" Progetti DM 1062 on 10/08/2021
6 · The paper itself

Abstract

Xylanase inhibitors (XIs) are plant cell wall proteins largely distributed in monocots that inhibit the hemicellulose degrading activity of microbial xylanases. XIs have been classified into three classes with different structures and inhibition specificities, namely

Indexed as

Endo-1,4-beta XylanasesPlant ProteinsEnzyme InhibitorsPlant ImmunityTriticumEndo-1,4-beta XylanasesEnzyme InhibitorsPlant Proteinsallergenicitycell deathcell wall degrading enzymes (CWDEs)food processinghemicelluloseplant defensexylanases

Identifiers

PMID36499321
PMCPMC9739030
OpenAlexW4311663894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.